Omega Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OMGA and other ETFs, options, and stocks.

About OMGA

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform.

CEO

Mahesh Karande

CEOMahesh Karande

Employees

Employees94

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2016

Founded2016

Employees

Employees94

OMGA Key Statistics

Market cap

124.37M

Market cap124.37M

Price-Earnings ratio

-1.43

Price-Earnings ratio-1.43

Dividend yield

—

Dividend yield—

Average volume

309.64K

Average volume309.64K

High today

$2.53

High today$2.53

Low today

$2.23

Low today$2.23

Open price

$2.53

Open price$2.53

Volume

514.30K

Volume514.30K

52 Week high

$10.09

52 Week high$10.09

52 Week low

$1.30

52 Week low$1.30

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Omega Therapeutics

Why Robinhood?

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. Show more

OMGA Key Statistics

Analyst ratings

100%

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform.